(Q42593290)

3 November 2017

Enhanced interaction between Hsp90 and raptor regulates mTOR signaling upon T cell activation (English)

1 reference

3 November 2017

Greg M Delgoffe

1

1 reference

3 November 2017

Thomas P Kole

series ordinal

2

1 reference

3 November 2017

Robert J Cotter

series ordinal

3

1 reference

3 November 2017

Jonathan D Powell

series ordinal

4

1 reference

3 November 2017

7 July 2009

1 reference

3 November 2017

1 reference

3 November 2017

46

1 reference

3 November 2017

13

1 reference

3 November 2017

2694-2698

1 reference

Hsp90: a novel target for the disruption of multiple signaling cascades

3 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768125

Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768125

Dissecting the mechanism of T-cell anergy with immunophilin ligands

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768125

mTOR and cancer: insights into a complex relationship

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768125

Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768125

Suppression of the mTOR-raptor signaling pathway by the inhibitor of heat shock protein 90 geldanamycin

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768125

Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768125

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768125

Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768125

Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19586661

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A role for mammalian target of rapamycin in regulating T cell activation versus anergy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19586661

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.MOLIMM.2009.05.185

1 reference

3 November 2017

1 reference

3 November 2017

1 reference